218 related articles for article (PubMed ID: 27419370)
1. Expression of neural cell adhesion molecule L1 (CD171) in neuroectodermal and other tumors: An immunohistochemical study of 5155 tumors and critical evaluation of CD171 prognostic value in gastrointestinal stromal tumors.
Inaguma S; Wang Z; Lasota JP; Miettinen MM
Oncotarget; 2016 Aug; 7(34):55276-55289. PubMed ID: 27419370
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1): Analysis in 5536 Cases Revealed Consistent Expression in Trophoblastic Tumors.
Inaguma S; Wang Z; Lasota J; Sarlomo-Rikala M; McCue PA; Ikeda H; Miettinen M
Am J Surg Pathol; 2016 Aug; 40(8):1133-42. PubMed ID: 27158757
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic and molecular characteristics of malignant gastrointestinal neuroectodermal tumors].
Zhao M; Zhao TW; Ma J; Wu CY; Chen L; Ru GQ; He XL
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):750-755. PubMed ID: 29136686
[No Abstract] [Full Text] [Related]
4. The immunohistochemical expression of CD24 and CD171 adhesion molecules in borderline ovarian tumors.
Moulla A; Miliaras D; Sioga A; Kaidoglou A; Economou L
Pol J Pathol; 2013 Oct; 64(3):180-4. PubMed ID: 24166603
[TBL] [Abstract][Full Text] [Related]
5. L1 is highly expressed in tumors of the nervous system: a study of over 8000 human tissues.
Rawnaq T; Quaas A; Zander H; Gros SJ; Reichelt U; Blessmann M; Wilzcak W; Schachner M; Sauter G; Izbicki JR; Kaifi JT
J Surg Res; 2012 Apr; 173(2):314-9. PubMed ID: 21195422
[TBL] [Abstract][Full Text] [Related]
6. Diverse solid tumors expressing a restricted epitope of L1-CAM can be targeted by chimeric antigen receptor redirected T lymphocytes.
Hong H; Stastny M; Brown C; Chang WC; Ostberg JR; Forman SJ; Jensen MC
J Immunother; 2014; 37(2):93-104. PubMed ID: 24509172
[TBL] [Abstract][Full Text] [Related]
7. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
8. CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing.
Andersch L; Radke J; Klaus A; Schwiebert S; Winkler A; Schumann E; Grunewald L; Zirngibl F; Flemmig C; Jensen MC; Rossig C; Joussen A; Henssen A; Eggert A; Schulte JH; Künkele A
BMC Cancer; 2019 Sep; 19(1):895. PubMed ID: 31500597
[TBL] [Abstract][Full Text] [Related]
9. Adhesion molecules CD171 (L1CAM) and CD24 are expressed by primary neuroendocrine carcinomas of the skin (Merkel cell carcinomas).
Deichmann M; Kurzen H; Egner U; Altevogt P; Hartschuh W
J Cutan Pathol; 2003 Jul; 30(6):363-8. PubMed ID: 12834484
[TBL] [Abstract][Full Text] [Related]
10. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.
Miettinen M; McCue PA; Sarlomo-Rikala M; Rys J; Czapiewski P; Wazny K; Langfort R; Waloszczyk P; Biernat W; Lasota J; Wang Z
Am J Surg Pathol; 2014 Jan; 38(1):13-22. PubMed ID: 24145643
[TBL] [Abstract][Full Text] [Related]
11. Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy.
Huszar M; Moldenhauer G; Gschwend V; Ben-Arie A; Altevogt P; Fogel M
Hum Pathol; 2006 Aug; 37(8):1000-8. PubMed ID: 16867862
[TBL] [Abstract][Full Text] [Related]
12. L1 (CD171) is highly expressed in gastrointestinal stromal tumors.
Kaifi JT; Strelow A; Schurr PG; Reichelt U; Yekebas EF; Wachowiak R; Quaas A; Strate T; Schaefer H; Sauter G; Schachner M; Izbicki JR
Mod Pathol; 2006 Mar; 19(3):399-406. PubMed ID: 16400320
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility.
Künkele A; Taraseviciute A; Finn LS; Johnson AJ; Berger C; Finney O; Chang CA; Rolczynski LS; Brown C; Mgebroff S; Berger M; Park JR; Jensen MC
Clin Cancer Res; 2017 Jan; 23(2):466-477. PubMed ID: 27390347
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients.
Zander H; Rawnaq T; von Wedemeyer M; Tachezy M; Kunkel M; Wolters G; Bockhorn M; Schachner M; Izbicki JR; Kaifi J
BMC Cancer; 2011 May; 11():189:1-7. PubMed ID: 21600041
[TBL] [Abstract][Full Text] [Related]
15. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.
Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG
World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092
[TBL] [Abstract][Full Text] [Related]
16. Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors.
Miettinen M; McCue PA; Sarlomo-Rikala M; Biernat W; Czapiewski P; Kopczynski J; Thompson LD; Lasota J; Wang Z; Fetsch JF
Am J Surg Pathol; 2015 Jun; 39(6):826-35. PubMed ID: 25724000
[TBL] [Abstract][Full Text] [Related]
17. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
[TBL] [Abstract][Full Text] [Related]
18. Malignant gastrointestinal neuroectodermal tumor: a case report and review of the literature.
Alyousef MJ; Alratroot JA; ElSharkawy T; Shawarby MA; Al Hamad MA; Hashem TM; Alsayyah A
Diagn Pathol; 2017 Mar; 12(1):29. PubMed ID: 28320420
[TBL] [Abstract][Full Text] [Related]
19. L1 (CAM) (CD171) in ovarian serous neoplasms.
Daponte A; Kostopoulou E; Kollia P; Papamichali R; Vanakara P; Hadjichristodoulou C; Nakou M; Samara S; Koukoulis G; Messinis IE
Eur J Gynaecol Oncol; 2008; 29(1):26-30. PubMed ID: 18386459
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of pfetin: a validation study in gastrointestinal stromal tumors using a commercially available antibody.
Kubota D; Mukaihara K; Yoshida A; Suehara Y; Saito T; Okubo T; Gotoh M; Orita H; Tsuda H; Kaneko K; Kawai A; Kondo T; Sato K; Yao T
Jpn J Clin Oncol; 2013 Jun; 43(6):669-75. PubMed ID: 23619989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
